Our previous studies have shown that somatotropin (ST) antagonizes insulin stimulation of fatty acid synthase (FAS) enzyme activity and gene transcription in adipocytes. In the present study, inhibitors of insulin and ST signaling pathways were used to dissect the mechanisms by which these hormones regulate FAS gene expression in 3T3-F442A adipocytes. Treating 3T3-F442A adipocytes with 10 M PD98059, an inhibitor of mitogen-activated protein (MAP) kinase, did not affect the induction of FAS mRNA by insulin. When cells were cultured with H-89 (10 M), GF109203X (10 M), or staurosporine (100 nM), inhibitors of protein kinase A, protein kinase C, and Janus
Introduction
Fatty acid synthase (FAS) is a key enzyme in the lipogenic pathway that catalyzes all the reactions in the conversion of acetyl-CoA and malonyl-CoA to palmitic acid. Fatty acid synthase activity, mRNA levels, and gene transcription are exquisitely sensitive to nutritional and hormonal manipulations (Hillgartner et al., 1995) . For example, our previous studies indicate that somatotropin (ST) dramatically attenuates the stimulatory effect of insulin on FAS mRNA abundance and gene transcription in rat liver and in 3T3-F442A adipocytes (Donkin et al., 1996b; Yin et al., 1998) . Little is known, however, about how ST affects the insulin signal pathway(s) to inhibit the stimulatory effect of insulin on FAS gene expression.
Several insulin signaling molecules and pathways have been identified (White, 1997 1194 kinase (JAK) 2, respectively, the inhibitory effect of ST on FAS mRNA levels was not altered. However, H-89 significantly decreased the stimulatory effect of insulin on FAS mRNA abundance. Moreover, treatment with okadaic acid (1 M), a serine/threonine phosphatase inhibitor, abolished the induction of FAS mRNA by insulin. These results suggest that serine/threonine dephosphorylation and protein kinase A-dependent pathways are involved in the regulation of FAS gene expression by insulin, but MAP kinase is probably not involved. Furthermore, our data indicate that protein kinase A, protein kinase C, and JAK2 do not mediate the effect of ST on regulation of FAS mRNA abundance.
receptor substrate (IRS) 1 activates phosphatidylinositol-3 (PI3) kinase and mitogen-activated protein (MAP) kinase (White, 1997) . Somatotropin induces a variety of metabolic effects after binding to its receptor. The early events of ST signal transduction pathways include activation of Janus kinase (JAK) 2 (Argetsinger and Carter-Su, 1996) . The enzyme MAP kinase and protein kinase C are also involved in ST signal pathways (Argetsinger and Carter-Su, 1996) . Several studies have shown that cAMP inhibits FAS gene expression in mouse liver and in 3T3-L1 adipocytes Sul, 1988, 1989) . However, it remains unclear whether cAMP, protein kinase C, and protein kinase A are involved in the insulin-antagonistic effects of ST on FAS gene expression. Thus, the present study was conducted to learn more about how various inhibitors of insulin or ST affected signaling of these hormones to the FAS gene.
Materials and Methods

Materials
The plasmid pcRFAS 40, containing a 1.8-kb EcoRIXhoI fragment of the rat FAS cDNA gene, was kindly provided by M. Schweizer (AFRC Norwich Lab, Norwich, U.K.). The plasmid pDF8, containing a 1.06-kb BamHI-EcoRI fragment of rat 18S rRNA cDNA gene, was kindly provided by R. Torczynski (Cytoclonal Pharmaceutics, Dallas, TX). The 3T3-F442A preadipocytes were kindly provided by H. Green (Harvard University, Boston, MA). Recombinant bovine somatotropin (bST) was a gift from Monsanto Company (R. Ryan, St. Louis, MO). Dulbecco's Modified Eagle's Medium (DMEM) was purchased from Life Technologies (Grand Island, NY). Sephadex G-50 spin columns were obtained from Boehringer Mannheim (Indianapolis, IN) . Insulin, calf serum, and fetal bovine serum were purchased from Sigma Chemical (St. Louis, MO). Genescreen and [ 32 P]-dCTP were from DuPont NEN (Boston, MA). Ready-ToGo random labeling kits were obtained from Pharmacia (Piscataway, NJ). Staurosporine, 8-(4-chlorophenylthio)-cAMP (cAMP), and hydrocortisone were purchased from Sigma Chemical. Okadaic acid, GF109203X, PD98059, and H-89 were purchased from Calbiochem (La Jolla, CA). All other chemicals were supplied by Sigma Chemical or Fisher Scientific (Pittsburgh, PA).
Cell Culture
The 3T3-F442A cells were maintained in DMEM with 10% calf serum in T-75 flasks at 37°C. To convert the cells to adipocytes, pre-confluent cells were incubated for 48 h in DMEM containing 10% fetal bovine serum and 2 g/mL insulin (Djian et al., 1985) . After 48 h, insulin was removed and cells were fed every 2 to 3 d with DMEM plus 10% fetal bovine serum until 80% of the cells were lipid-filled. Cells were then cultured for 24 h in defined medium (DMEM plus 2% BSA, 5 g/mL transferrin, 2 ng/mL selenium, 10 ng/mL α-tocopherol, and 1 nM thyroid hormone) prior to the addition of insulin and(or) bST. Insulin (10 ng/mL) and bST (100 ng/mL) were added to the defined medium containing hydrocortisone (50 ng/mL) for the indicated periods of time. Defined medium plus hydrocortisone was the control medium for all experiments.
Northern Blot Analysis
Total RNA was extracted as described by Chomczynski and Sacchi (1987) . The Northern blot analysis was conducted as described previously (Yin et al., 1998) . In brief, 15 g of total RNA was separated by electrophoresis on a 1.0 %-agarose gel and transferred to Genescreen membranes. The RNA was UV-crosslinked to the membrane and baked for 2 h at 80°C. Prehybridization and hybridization solutions contained 50% deionized formamide, 5× Denhardt's solution, 0.75 M NaCl, 50 mM NaH 2 PO 4 , 5 mM EDTA, 10% dextran sulfate, 1% SDS, and 200 g/mL salmon sperm DNA. Membranes were prehybridized at 42°C overnight. The rat FAS cDNA (50 ng) was labeled with 50 Ci of [ 32 P]dCTP using the Ready-To-Go random labeling kit. Hybridization fluid containing 1 ×10 6 cpm of probe/mL was added and the membrane was hybridized for 24 h at 42°C. Membranes were then washed twice for 5 min each at room temperature in 0.3 M sodium chloride, 0.03 M sodium citrate, twice for 30 min each at 65°C in 0.3 M sodium chloride, 0.03 M sodium citrate, 1% SDS, and twice for 30 min each at room temperature in 15 mM sodium chloride, 1.5 mM sodium citrate. Membranes were then exposed to Kodak X-Omat AR film at −70°C for approximately 2 to 3 days. Membranes were stripped in 15 mM sodium chloride, 1.5 mM sodium citrate, and 1% SDS at 100°C for 1 h and then reprobed with the cDNA for rat 18S rRNA to assess variation in loading or transfer of RNA.
Statistical Analysis
Results were analyzed using the General Linear Model procedures of SAS (SAS Inst. Inc., Cary, NC). The mean separation procedure used was a T multiple comparison. All data are presented as the mean ± SEM.
Results
Role of Protein Kinase A Inhibitor and cAMP on Regulation of FAS Gene Expression by Insulin and ST
Previous studies have demonstrated that cAMP antagonizes the stimulatory effect of insulin on FAS protein content and promoter activity in H4IIE cells (Rangan et al., 1996) . Furthermore, recent studies demonstrated that cAMP (0.25 to 2.5 mM) was shown to significantly increase osterocalcin gene transcription in human and rat osteoblast-like cell lines (Boguslawski et al., 2000) . In contrast, H-89 (0.1 to 10 M), an inhibitor of protein kinase A, inhibited osterocalcin gene transcription induced by forskolin, an activator of adenylyl cyclase (Boguslawski et al., 2000) . In order to examine whether cAMP mediated the effect of ST on insulin stimulation of FAS mRNA levels in 3T3-F442A adipocytes, cells were treated with 0.5 mM cAMP. As shown in Figure 1 , cAMP did not decrease the insulin stimulation of FAS mRNA, nor did cAMP treatment alter the insulin-antagonistic effect of ST. When cells were treated with insulin (10 ng/mL) or insulin (10 ng/mL) plus bST (100 ng/mL) for 48 h in the presence of 10 M H-89, the insulin stimulation of FAS mRNA levels was significantly decreased from 5-fold to 2.2-fold (P < 0.05), although insulin still had a significantly stimulatory effect on FAS mRNA levels ( Figure 1 ). However, H-89 had little effect on the regulation of FAS gene expression by bST, whereas bST decreased the stimulatory effect of insulin on FAS mRNA abundance by 57% (Figure 1 ). In agreement with our previous observations that in vitro porcine ST (pST) alone did not affect fatty acid synthesis in pig adipose tissue , bST alone did not significantly affect FAS mRNA levels in 3T3-F442A adipocytes (Figure 1 ).
Serine/Threonine Dephosphorylation(s), but Not JAK2, Are Involved in the Regulation of FAS Gene Expression by Insulin or ST
In our previous studies, dephosphorylation positively regulated the binding of upstream stimulatory factor Figure 1 . Effects of H-89 and cAMP on the regulation of FAS gene expression by insulin and ST. The 3T3-F442A adipocytes were cultured in defined medium (Con) or medium that contained 10 ng/mL of insulin (Ins), insulin (10 ng/mL) plus 100 ng/mL of bST (Ins + ST), or 100 ng/ mL bST (ST) in the presence of 10 M H-89 or 0.5 mM cAMP or without inhibitors for 48 h. Total RNA (15 g) was hybridized with the rat FAS cDNA probe as described in the Materials and Methods section. A representative blot is shown in panel A. Four independent experiments were conducted and the blots were scanned and normalized using the rat 18S rRNA to account for differences in loading. Panel B shows the mean ± SEM of FAS mRNA abundance (n = 4). Means with different superscripts within an inhibitor are significantly different (P < 0.05).
(USF) 1 to the FAS insulin response element (FAS-IRE) (D. Yin and T. D. Etherton, unpublished results). Treating sheep adipose tissue explants with 25 nM okadaic acid, an inhibitor of serine/threonine phosphatases, resulted in a marked inhibition of lipogenesis induced by insulin (Vernon, 1996) . In addition, okadaic acid also decreased the insulin-antagonistic effect of ST on lipogenesis (Vernon, 1996) . More recently, 1 M okadaic acid was shown to inhibit insulin-induced glucose transport in rat fetal brown adipocytes (Valverde et al., 2000) . To determine whether dephosphorylation was required for the insulin regulation of FAS gene Figure 2 . Effects of okadaic acid and staurosporine on the regulation of FAS gene expression by insulin and ST. The 3T3-F442A adipocytes were cultured in defined medium (Con) or medium that contained 10 ng/mL of insulin (Ins), insulin (10 ng/mL) plus 100 ng/mL of bST (ST) in the presence of 1 M okadaic acid or 100 nM staurosporine or without inhibitors for 48 h. Total RNA (15 g) was hybridized with the rat FAS cDNA probe as described in the Materials and Methods section. A representative blot is shown in panel A. Four independent experiments were conducted and the blots were scanned and normalized using the rat 18S rRNA to account for differences in loading. Panel B shows the mean ± SEM of FAS mRNA abundance (n = 4). Means with different superscripts within an inhibitor are significantly different (P < 0.05).
expression, 1 M okadaic acid was added with insulin or insulin plus bST for 48 h. Addition of okadaic acid abolished the stimulatory effects of insulin on FAS mRNA levels (P < 0.05) (Figure 2 ). In the absence of any stimulatory effect of insulin, ST had no significant effect on FAS mRNA abundance (Figure 2) .
It is evident that JAK2 is an important molecule in ST receptor signaling that seems to mediate many of the biological effects attributable to ST. A previous study reported that staurosporine (100 nM), a tyrosine kinase inhibitor, abolished promotion of JAK2 tyrosine phosphorylation induced by ST and the acute ST stimulation of lipogenesis in rat adipocytes (Ridderstrale and Tornqvist, 1996) . However, staurosporine (10 to 100 nM) did not affect the chronic effects of insulin and ST on the rate of lipogenesis of sheep adipose tissue explants (Vernon, 1996) . In the present study, 100 nM staurosporine did not alter the inhibitory effect of ST on the effects of insulin on FAS mRNA levels in 3T3-F442A adipocytes (Figure 2) . However, staurosporine markedly enhanced the insulin stimulation of FAS mRNA (P < 0.05) (Figure 2 ).
Neither MAP Kinase Nor Protein Kinase C is Involved in the Regulation of FAS Gene Expression by Insulin or ST
Insulin stimulated MAP kinase activity in sheep adipocytes (Wilson et al., 1996) . Previous studies showed that pretreatment of 3T3-L1 adipocytes with PD98059, a specific MAP kinase inhibitor, completely abolished the stimulation of MAP kinase by insulin with an IC 50 of 1 M and a maximal inhibitory effect obtained with 10 M (Lazar et al., 1995) . However, 10 M PD98059 did not block the stimulation of glucose utilization by insulin (Lazar et al., 1995) . Similarly, PD98059 had no effect on ST inhibition of lipogenesis in sheep adipose tissue (Vernon, 2000) . Protein kinase C was shown to be involved in ST signal pathways (Argetsinger and Carter-Su, 1996) . Recent studies indicated that both inhibition of polyamine synthesis and down-regulation of protein kinase C isoforms by pretreatment with phorbol ester abolished effects of ST on lipogenesis in explants of sheep adipose tissue (Vernon, 2000) . However, either alone had only a partial effect on lipogenesis (Vernon, 2000) . Previous studies demonstrated that 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced phosphorylation of MARCKS-p80 (a well-known endogenous protein kinase C substrate) in NIH 3T3 cells was prevented by GF109203X, a nontoxic protein kinase C inhibitor, at a concentration of 0.1 M (Crespo et al., 1994) . Furthermore, 1 M GF109203X efficiently abolished DNA synthesis induced by TPA in NIH 3T3 cells (Crespo et al., 1994) . In order to assess whether MAP kinase and protein kinase C were involved in the regulation of FAS gene expression by insulin and bST, PD98059 and GF109203X were evaluated. Neither GF109203X (10 M) nor PD98059 (10 M) altered the effects of insulin and bST on FAS gene expression (Figure 3) . Thus, a MAP kinase-and protein kinase Cindependent pathway existed for regulation of FAS gene expression by insulin and bST in 3T3-F442A adipocytes. Notably, staurosporine was found to also inhibit protein kinase C activity from rat brain with an IC 50 of 2.7 nM (Tamaoki et al., 1986 ). As stated above, 100 M of staurosporine did not affect the insulin-antagonistic effect of ST on FAS gene expression, sug- Figure 3 . Effects of GF109203X and PD98059 on the regulation of FAS gene expression by insulin and ST. The 3T3-F442A adipocytes were cultured in defined medium (Con) or medium that contained 10 ng/mL of insulin (Ins), insulin (10 ng/mL) plus 100 ng/mL of bST (ST) in the presence of 10 M GF109203X or 10 M PD98059 or without inhibitors for 48 h. Total RNA (15 g) was hybridized with the rat FAS cDNA probe as described in the Materials and Methods section. A representative blot is shown in panel A. Three independent experiments were conducted and the blots were scanned and normalized using the rat 18S rRNA to account for differences in loading. Panel B shows the mean ± SEM of FAS mRNA abundance (n = 3). Neither GF109203X nor PD98059 had significant effects on regulation of FAS mRNA abundance by insulin and bST.
gesting that both protein kinase C and JAK2 were not involved in the ST signal pathways to the FAS gene.
Discussion
An impressive body of evidence indicates that ST dramatically decreases lipogenesis in adipose tissue of growing pigs (Etherton and Bauman, 1998) . This decrease occurs as the result of a ST-dependent reduction in insulin sensitivity and responsiveness in adipocytes (Etherton and Bauman, 1998) . The available data indicate that the pST-dependent decrease in lipogenesis is due to a marked decrease in the activity of several insulin-stimulated lipogenic enzymes, including FAS (Magri et al., 1990; Donkin et al., 1996a) . The pSTdependent decrease in the lipogenesis is not the result of any change in insulin binding or insulin receptor kinase activity, suggesting that the pST-dependent impairment in insulin signaling occurs at some point distal to the insulin receptor (Magri et al., 1990) . Furthermore, inhibiting gene transcription by actinomycin D in sheep adipose tissue blocks the inhibitory effect of ST on lipogenesis, suggesting that gene transcription is required for the ST effect to occur (Borland et al., 1994) . Our previous studies indicate that ST reduces FAS mRNA abundance as the result of a decrease in gene transcription both in rat liver and cultured 3T3-F442A adipocytes (Donkin et al., 1996b; Yin et al., 1998) . We are unaware of studies that have addressed this question in adipocytes of domestic animals. Nonetheless, it seems reasonable to speculate that FAS gene transcription in pig adipocytes may respond to ST in a similar manner. To date, we are unaware of any evidence that the ST signaling pathways to the FAS gene may function differently in meat animal species.
It is evident that MAP kinase is an important intermediate for insulin signaling. Several studies have shown that MAP kinase is activated by a variety of agents, including insulin and ST (Argetsinger and Carter-Su, 1996) . The MAP kinase has been shown to mediate the effects of both insulin and ST on the regulation of c-fos gene expression (Cohen, 1993) . However, PD 98059 has no effect on ST inhibition of lipogenesis in sheep adipose tissue (Vernon, 2000) . The results of the present study establish for the first time that PD98059 does not alter the regulation of FAS mRNA levels by insulin and ST, suggesting that MAP kinase is not involved in the regulation of FAS gene expression by insulin or ST.
It has been well documented that phosphorylation or dephosphorylation modulates activity of transcription factors (Hunter and Karin, 1992) . Previous experiments in our laboratory suggest that protein phosphatase treatment increases and phosphatase inhibitors decrease the binding of USF1 to the FAS-insulin response element. This observation led to the hypothesis that protein dephosphorylation might be a prerequisite for the regulation of the FAS gene by insulin. In support of this hypothesis, we found that treating 3T3-F442A adipocytes with okadaic acid abolished the stimulatory effects of insulin on FAS mRNA abundance. Therefore, a serine/threonine dephosphorylation-dependent step(s) is involved in the regulation of FAS gene expression by insulin. Notably, several studies have found that okadaic acid exerts either insulin-like or insulinantagonistic effects on gene expression (O'Brien and Granner, 1996) . For example, okadaic acid has an insulin-like effect on phosphoenolpyruvate carboxykinase gene expression in hepatocytes (O'Brien et al., 1994) . In contrast, okadaic acid inhibits the insulin-stimulated glucokinase gene expression in hepatocytes (Agius and Peak, 1991) . Furthermore, okadaic acid treatment inhibits insulin-induced lipogenesis and decreases the insulin-antagonistic effect of ST on lipogenesis in sheep adipose tissue explants (Vernon, 1996) . Recent studies indicate that serine phosphorylation of IRS-1 and IRS-2 induced by okadaic acid inhibits insulin-induced glucose transport in rat fetal brown adipocytes (Valverde et al., 2000) . Interestingly, serine phosphorylation of IRS-1 induced by okadaic acid prevents JAK1-dependent tyrosine phosphorylation of IRS-1 (Cengel and Freund, 1999) . Thus, IRS-1 serine phosphorylation may play a counter-regulatory role in pathways outside the insulin signaling system. It is possible that ST may mimic the effect of okadaic acid on induction of serine phosphorylation of IRS-1 to attenuate insulin receptor signaling. Whether ST induces serine phosphorylation of IRS-1 remains to be determined.
Previous studies have demonstrated that cAMP abolishes the effects of insulin on FAS protein content and FAS gene transcription in H4IIE cells (Rangan et al., 1996) . In the present study, however, cAMP did not significantly inhibit the effects of insulin on FAS mRNA abundance in 3T3-F442A adipocytes. It is not clear why we saw this response. One consideration is that the effect of cAMP may be tissue-specific. It is evident that cAMP regulates gene expression primarily via activation of protein kinase A (Jacob and Stanley, 1994; Klemm et al., 1998) . The present study has shown that treating cells with H-89 does not significantly alter the effect of bST on FAS mRNA levels. Thus, neither protein kinase A nor cAMP seems to be involved in mediating the effect of bST on FAS gene expression. However, H-89 significantly decreased the stimulatory effect of insulin on FAS mRNA levels, suggesting that protein kinase A is involved in the regulation of FAS gene expression by insulin. Based on the fact that insulin still increased FAS mRNA levels significantly in the presence of protein kinase A inhibitor, it seems that there is a protein kinase A-independent pathway(s) that exists in the insulin signal pathway to the FAS gene.
Protein kinase C has been shown to mediate the effects of both insulin and ST on the regulation of c-fos gene expression (Doglio et al., 1989; Stumpo et al., 1994) . Recent studies indicate that both inhibition of polyamine synthesis and down-regulation of protein kinase C isoforms by pretreatment with phorbol ester abolish effects of ST on lipogenesis in explants of sheep adipose tissue (Vernon, 2000) . However, the present study has shown that protein kinase C does not mediate the effects of insulin and ST on FAS gene expression.
It is well established that JAK2 is an important molecule for the ST signaling. Numerous studies indicate that JAK2 is involved in a variety of cytokine actions, including those of ST (Argetsinger and Carter-Su, 1996) . Thus, biological specificity of these signal pathways as well as that for ST must occur at some level other than JAK2 activation. For example, mutation of conserved box 1 region of the ST receptor, which is responsible for binding and activation of JAK2 kinase, does not affect ST-induced intracellular free Ca 2+ oscillations (Billestrup et al., 1995) . Thus, a JAK2-independent pathway is required for calcium uptake. Our results demonstrate that inhibition of JAK2 tyrosine phosphorylation does not block the effect of ST on FAS mRNA levels, suggesting that tyrosine phosphorylation of JAK2 is not involved in the regulation of FAS gene expression by ST. In contrast, the present study demonstrates that staurosporine significantly enhances the effect of insulin on FAS mRNA. It is not clear how staurosporine increases the effect of insulin on FAS gene expression. We are unaware of studies that have identified other signal pathways for ST in addition to JAK2. Further studies are necessary to identify what signaling molecules are involved in the ST signal pathway to inhibit the insulin-stimulated expression of the FAS gene. One possible ST signaling pathway is that ST induces serine phosphorylation of IRS-1 to interfere with insulin-induced tyrosine phosphorylation of IRS-1 and, hence, attenuate insulin receptor signaling. Another possible candidate for these signal molecules is sterol response element binding protein (SREBP) 1. The SREBP1 has been shown to bind to a sterol response element site at −150 to −141 in the rat FAS promoter and is required for the down-regulation of FAS gene transcription by sterol treatment (Bennett et al., 1995) . More importantly, Kim et al. (1998) recently demonstrated that the abundance of SREBP1 was reduced dramatically upon withholding of feed and elevated upon refeeding and insulin treatment, suggesting that SREBP1 may be a response factor for the regulation of FAS gene transcription by nutritional and insulin manipulations. However, it is unclear whether SREBP1 is involved in the regulation of FAS gene transcription by insulin or ST.
Implications
Somatotropin (ST) antagonizes insulin stimulation of fatty acid synthase (FAS) gene transcription in adipocytes, but it is not clear how ST interferes with insulin signaling to attenuate FAS gene transcription. Our data indicate that serine/threonine dephosphorylation and protein kinase A-dependent pathways are involved in the regulation of FAS gene expression by insulin, but protein kinase A, protein kinase C, and Janus kinase 2 do not mediate the effect of ST on regulation of FAS mRNA abundance. Thus, ST seems to have unidentified pathways that account for the effects of ST in adipocytes. Further study of the ST signaling pathways in adipocytes may yield insights into new stimulatory effects of ST.
